259 related articles for article (PubMed ID: 19279120)
1. Rituximab therapy for membranous nephropathy: a systematic review.
Bomback AS; Derebail VK; McGregor JG; Kshirsagar AV; Falk RJ; Nachman PH
Clin J Am Soc Nephrol; 2009 Apr; 4(4):734-44. PubMed ID: 19279120
[TBL] [Abstract][Full Text] [Related]
2. Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.
Ruggenenti P; Cravedi P; Sghirlanzoni MC; Gagliardini E; Conti S; Gaspari F; Marchetti G; Abbate M; Remuzzi G
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1652-9. PubMed ID: 18684896
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.
Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL
Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
[TBL] [Abstract][Full Text] [Related]
6. Rituximab in idiopathic membranous nephropathy.
Ruggenenti P; Cravedi P; Chianca A; Perna A; Ruggiero B; Gaspari F; Rambaldi A; Marasà M; Remuzzi G
J Am Soc Nephrol; 2012 Aug; 23(8):1416-25. PubMed ID: 22822077
[TBL] [Abstract][Full Text] [Related]
7. Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.
Podestà MA; Trillini M; Portalupi V; Gennarini A; Tomatis F; Villa A; Perna A; Rubis N; Remuzzi G; Ruggenenti P
Am J Kidney Dis; 2024 Mar; 83(3):340-349.e1. PubMed ID: 37777061
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
Lu W; Gong S; Li J; Luo H; Wang Y
Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rituximab therapy for membranous nephropathy: a meta-analysis.
Zhang J; Bian L; Ma FZ; Jia Y; Lin P
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):8021-8029. PubMed ID: 30536351
[TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.
Fervenza FC; Abraham RS; Erickson SB; Irazabal MV; Eirin A; Specks U; Nachman PH; Bergstralh EJ; Leung N; Cosio FG; Hogan MC; Dillon JJ; Hickson LJ; Li X; Cattran DC;
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2188-98. PubMed ID: 20705965
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.
Melander C; Sallée M; Trolliet P; Candon S; Belenfant X; Daugas E; Rémy P; Zarrouk V; Pillebout E; Jacquot C; Boffa JJ; Karras A; Masse V; Lesavre P; Elie C; Brocheriou I; Knebelmann B; Noël LH; Fakhouri F
Clin J Am Soc Nephrol; 2009 Mar; 4(3):579-87. PubMed ID: 19261822
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC
J Nephrol; 2022 May; 35(4):1159-1170. PubMed ID: 35199314
[TBL] [Abstract][Full Text] [Related]
13. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
[TBL] [Abstract][Full Text] [Related]
14. Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.
Kong WY; Swaminathan R; Irish A
Int Urol Nephrol; 2013 Jun; 45(3):795-802. PubMed ID: 22798030
[TBL] [Abstract][Full Text] [Related]
15. Latest treatment strategies for membranous nephropathy.
Ruggenenti P; Cravedi P; Remuzzi G
Expert Opin Pharmacother; 2007 Dec; 8(18):3159-71. PubMed ID: 18035960
[TBL] [Abstract][Full Text] [Related]
16. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC; Appel GB; Barbour SJ; Rovin BH; Lafayette RA; Aslam N; Jefferson JA; Gipson PE; Rizk DV; Sedor JR; Simon JF; McCarthy ET; Brenchley P; Sethi S; Avila-Casado C; Beanlands H; Lieske JC; Philibert D; Li T; Thomas LF; Green DF; Juncos LA; Beara-Lasic L; Blumenthal SS; Sussman AN; Erickson SB; Hladunewich M; Canetta PA; Hebert LA; Leung N; Radhakrishnan J; Reich HN; Parikh SV; Gipson DS; Lee DK; da Costa BR; Jüni P; Cattran DC;
N Engl J Med; 2019 Jul; 381(1):36-46. PubMed ID: 31269364
[TBL] [Abstract][Full Text] [Related]
17. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in primary membranous nephropathy: first-line therapy, why not?
Cravedi P; Remuzzi G; Ruggenenti P
Nephron Clin Pract; 2014; 128(3-4):261-9. PubMed ID: 25427622
[TBL] [Abstract][Full Text] [Related]
19. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient.
Gallon L; Chhabra D
Am J Transplant; 2006 Dec; 6(12):3017-21. PubMed ID: 17294527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
